In addition to expression in T-cell malignancies, CD4 antigen is also expressed in a subtype of AML; therefore, CD4 CAR-NK cells also exhibit potent antileukemic activity against CD4+ AML (103). The gene discussed is CD4; the disease is acute myeloid leukemia.